# A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis

> **NCT02336503** · PHASE2 · COMPLETED · sponsor: **Botanix Pharmaceuticals** · enrollment: 189 (actual)

## Conditions studied

- Hyperhidrosis

## Interventions

- **DRUG:** BBI-4000 Gel, 5%
- **DRUG:** BBI-4000 Gel, 10%
- **DRUG:** BBI-4000 Gel, 15%
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT02336503
- **Lead sponsor:** Botanix Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-10
- **Primary completion:** 2015-11-05
- **Final completion:** 2015-11-05
- **Target enrollment:** 189 (ACTUAL)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02336503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02336503, "A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02336503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*